COMBIGENE AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.68 SEK | +0.82% |
|
-3.16% | +36.80% |
| 03-13 | CombiGene's Epilepsy Project CG01 Receives Patent in Two New Countries | CI |
| 02-21 | Orphazyme A/S acquired an additional unknown minority stake in CombiGene AB (OM:COMBI). | CI |
Quotes 5-day view
Delayed Quote Nasdaq Stockholm| 2024-04-26 | 2024-04-29 | 2024-04-30 | Today | 2024-05-02 | |
|---|---|---|---|---|---|
| Last | 3.77 kr | 3.75 kr | 3.65 kr | 3.68 kr | 3.68 kr |
| Volume | 5 340 | 6 541 | 675 | 4 075 | 4 075 |
| Change | +0.27% | -0.53% | -2.67% | +0.82% | +0.82% |
| Opening | 3.76 | 3.77 | 3.75 | 3.61 | 3.61 |
| High | 3.87 | 3.84 | 3.75 | 3.80 | 3.8 |
| Low | 3.76 | 3.71 | 3.65 | 3.61 | 3.61 |
Performance
| 1 day | +0.82% | ||
| 1 week | -3.16% | ||
| Current month | +3.08% | ||
| 1 month | -1.87% | ||
| 3 months | +16.83% | ||
| 6 months | +48.09% | ||
| Current year | +36.80% | ||
| 1 year | -47.43% | ||
| 3 years | -56.19% | ||
| 5 years | -85.85% |
Volumes
marketsDaily volume
4 075
Estimated daily volume
4 075
Avg. Volume 20 sessions
14 840
Daily volume ratio
0.27
Avg. Volume 20 sessions SEK
54 611.20
Avg. Volume 20 sessions USD
5 030.18
Record volume 1
17 345 640
Record volume 2
16 002 620
Record volume 3
4 467 464
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (SEK)
71 515 085
Capitalization (USD)
6 587 183
Net sales (SEK)
28 732 524
Net sales (USD)
2 646 524
Number of employees
11
Sales / Employee (SEK)
2 612 048
Sales / Employee (USD)
240 593
Free-Float
69.54 %
Free-Float capitalization (SEK)
49 730 592
Free-Float capitalization (USD)
4 580 635
Average Daily Capital Traded
0.08%
Highs and lows
1 week
3.61
3.89
1 month
3.554.30
Current year
2.664.30
1 year
2.008.10
3 years
2.0020.05
5 years
2.0033.90
10 years
2.00386.00
Indicators
Moving average 5 days
3.75
Moving average 20 days
3.87
Moving average 50 days
3.73
Moving average 100 days
3.33
Price spread / (MMA5)
+1.79%
Price spread / (MMA20)
+5.29%
Price spread / (MMA50)
+1.47%
Price spread / (MMA100)
-9.46%
STIM
RSI 9 days
41.92
RSI 14 days
47.03
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +0.82% | -3.16% | +36.80% | -47.43% | 6.59M | ||
| -0.49% | +0.62% | -1.65% | +15.64% | 104B | ||
| +3.78% | +5.27% | +6.75% | +17.43% | 97.47B | ||
| +3.51% | +3.98% | +5.71% | +0.78% | 22.25B | ||
| +2.55% | +6.38% | -12.60% | -16.95% | 21.68B | ||
| -0.99% | -3.09% | -9.70% | -30.35% | 18.2B | ||
| -2.02% | +3.73% | -39.98% | -35.33% | 17.02B | ||
| +3.50% | +9.05% | -10.17% | -38.50% | 16.36B | ||
| -2.24% | +1.50% | +6.12% | +35.17% | 14.39B | ||
| -0.21% | +2.54% | +35.47% | +5.61% | 12.37B | ||
| -0.88% | +10.02% | +307.09% | +260.76% | 8.43B | ||
| +0.06% | +3.05% | +12.03% | +64.09% | 8.06B | ||
| +4.43% | +3.40% | -23.67% | -30.03% | 8B | ||
| -0.07% | +1.26% | +0.47% | +37.89% | 7.74B | ||
| +5.97% | +12.17% | -50.81% | -68.69% | 7.31B | ||
| +1.32% | +7.48% | +2.79% | +37.22% | 6.93B | ||
| Average | +0.92% | +2.86% | +16.54% | +12.96% | ||
| Weighted average by Cap. | +1.09% | +1.56% | +5.38% | +11.59% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
d44fcae0d532.a7gB-S8qHmiTLXRkSa2vpMEMs1lbZ0TBwbQqYWhSBX8.M99RtHd6Rlz7HCM7HMPM8qs68Wg4LXOx-cBICxkBcC4z31LJfB1tGsZHNQ
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 10:36:58 | 3.68 | 410 | 4,075 |
| 09:16:33 | 3.67 | 800 | 3,665 |
| 06:23:56 | 3.8 | 150 | 2,865 |
| 05:17:11 | 3.74 | 379 | 2,715 |
| 05:16:27 | 3.74 | 64 | 2,336 |
| 04:54:00 | 3.73 | 1,500 | 2,272 |
| 04:22:15 | 3.65 | 3 | 772 |
| 04:10:45 | 3.65 | 40 | 769 |
| 04:10:34 | 3.65 | 7 | 729 |
| 03:07:34 | 3.62 | 50 | 722 |
Monthly variations
Annual change
| 2024 | +36.80% | ||
| 2023 | -70.55% | ||
| 2022 | -19.87% | ||
| 2021 | -16.91% | ||
| 2020 | -37.35% | ||
| 2019 | -28.90% | ||
| 2018 | -28.37% | ||
| 2017 | -44.87% | ||
| 2016 | -64.22% | ||
| 2015 | +21.79% |
- Stock Market
- Equities
- COMBI Stock
- Quotes CombiGene AB
